MIAMI, Jan. 28, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that is ...
Tevogen Bio announces a broadening of its relationship with Microsoft to expand its AI-focused collaboration and build PredicTcell. Tevogen will integrate Microsoft's AI tools to help expand the ...
Tevogen Bio is also proactively investigating potential treatments for Human Papillomavirus (HPV). WARREN, N.J., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback